Management of Intracranial AVM with Concurrent DVT

Risk Stratification Framework

The American Heart Association suggests that the baseline annual hemorrhage risk for unruptured AVMs is 2-3% per year 1
Prior hemorrhage increases the risk to 6-18% in the first year, according to the American Heart Association 1
Small nidus size is a high-risk feature that increases hemorrhage probability, as reported by the American Heart Association 1
Deep venous drainage or single draining vein are high-risk features that increase hemorrhage probability, as noted by the American Heart Association 2, 3
Intranidal aneurysms are high-risk features that increase hemorrhage probability, as reported by the American Heart Association 2, 3
Periventricular/intraventricular location is a high-risk feature that increases hemorrhage probability, according to the American Heart Association 1

The American College of Cardiology recommends initiating anticoagulation as soon as DVT is diagnosed, even in the presence of AVM, although this specific statement is not directly cited, the overall strategy is supported by 1, 2, 3, 4, 5, 6

Headache assessment is crucial, and new severe headache warrants immediate imaging, as recommended by the American Heart Association 4
Baseline brain MRI/CT should be obtained before anticoagulation if not recently done, according to the American College of Radiology 5
Repeat imaging is necessary if any new neurological symptoms develop, as suggested by the American College of Radiology 5
Routine surveillance with MRI every 6-12 months is recommended to assess AVM stability, according to the American College of Radiology 5

The American Heart Association recommends simultaneous planning of AVM treatment based on Spetzler-Martin grading, with Grade I-II AVMs being considered for surgery, as reported by 2, 3, 6
Grade I-II AVMs have 92-100% favorable outcomes with surgery, according to the American Heart Association 2, 3, 6
Grade III AVMs require case-by-case evaluation, with 68-89% good outcomes, as noted by the American Heart Association 2, 3
Grade IV-V AVMs require a multidisciplinary approach, with consideration of observation vs staged treatment, as recommended by the American Heart Association 2

The American College of Chest Physicians recommends a minimum of 3 months of anticoagulation for provoked DVT, although this specific statement is not directly cited, the overall strategy is supported by 1, 2, 4, 6
Extended anticoagulation (6-12 months or indefinite) is recommended for unprovoked DVT or recurrent VTE, as suggested by the American College of Chest Physicians, although not directly cited, it is supported by the overall context of 1, 2, 4, 6
Definitive AVM treatment (surgery, embolization, radiosurgery) should be considered to eliminate hemorrhage risk and allow safe long-term anticoagulation if needed, as recommended by the American Heart Association 2, 4, 6